(Q54610896)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16580882%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

title

Stimulating full-length SMN2 expression by delivering bifunctional RNAs via a viral vector (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16580882%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16580882%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

author name string

Travis Baughan

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16580882%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Monir Shababi

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16580882%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Tristan H Coady

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16580882%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Alexa M Dickson

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16580882%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Christian L Lorson

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16580882%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

publication date

31 March 2006

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16580882%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16580882%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

volume

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16580882%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16580882%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

page(s)

54-62

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16580882%20AND%20SRC:MED&resulttype=core&format=json

The neurobiology of childhood spinal muscular atrophy.

18 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.01.012

Quantitative analysis of survival motor neuron copies: identification of subtle SMN1 mutations in patients with spinal muscular atrophy, genotype-phenotype correlation, and implications for genetic counseling

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.01.012

Disruption of an SF2/ASF-dependent exonic splicing enhancer in SMN2 causes spinal muscular atrophy in the absence of SMN1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.01.012

A single nucleotide in the SMN gene regulates splicing and is responsible for spinal muscular atrophy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.01.012

An exonic enhancer is required for inclusion of an essential exon in the SMA-determining gene SMN

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.01.012

Htra2-beta 1 stimulates an exonic splicing enhancer and can restore full-length SMN expression to survival motor neuron 2 (SMN2)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.01.012

hnRNP-G promotes exon 7 inclusion of survival motor neuron (SMN) via direct interaction with Htra2-beta1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.01.012

SRp30c-dependent stimulation of survival motor neuron (SMN) exon 7 inclusion is facilitated by a direct interaction with hTra2 beta 1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.01.012

A negative element in SMN2 exon 7 inhibits splicing in spinal muscular atrophy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.01.012

An extended inhibitory context causes skipping of exon 7 of SMN2 in spinal muscular atrophy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.01.012

In vivo selection reveals combinatorial controls that define a critical exon in the spinal muscular atrophy genes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.01.012

The regulation and regulatory activities of alternative splicing of the SMN gene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.01.012

Identification of a cis-acting element for the regulation of SMN exon 7 splicing

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.01.012

An intronic splicing enhancer element in survival motor neuron (SMN) pre-mRNA.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.01.012

The role of histone acetylation in SMN gene expression.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.01.012

Valproic acid increases the SMN2 protein level: a well-known drug as a potential therapy for spinal muscular atrophy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.01.012

Valproic acid increases SMN levels in spinal muscular atrophy patient cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.01.012

Phenylbutyrate increases SMN expression in vitro: relevance for treatment of spinal muscular atrophy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.01.012

Phenylbutyrate increases SMN gene expression in spinal muscular atrophy patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.01.012

Treatment of spinal muscular atrophy by sodium butyrate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.01.012

Hydroxyurea enhances SMN2 gene expression in spinal muscular atrophy cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.01.012

Aclarubicin treatment restores SMN levels to cells derived from type I spinal muscular atrophy patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.01.012

Diverse small-molecule modulators of SMN expression found by high-throughput compound screening: early leads towards a therapeutic for spinal muscular atrophy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.01.012

Indoprofen upregulates the survival motor neuron protein through a cyclooxygenase-independent mechanism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.01.012

Correction of SMN2 Pre-mRNA splicing by antisense U7 small nuclear RNAs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.01.012

Modulation of survival motor neuron pre-mRNA splicing by inhibition of alternative 3' splice site pairing

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.01.012

In Vitro Restoration of Functional SMN Protein in Human Trophoblast Cells Affected by Spinal Muscular Atrophy by Small Fragment Homologous Replacement

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.01.012

Correction of disease-associated exon skipping by synthetic exon-specific activators

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.01.012

Bifunctional antisense oligonucleotides provide a trans-acting splicing enhancer that stimulates SMN2 gene expression in patient fibroblasts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.01.012

ESEfinder: A web resource to identify exonic splicing enhancers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.01.012

The survival motor neuron protein in spinal muscular atrophy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.01.012

Messenger RNA reprogramming by spliceosome-mediated RNA trans-splicing

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.01.012

Alternative splicing in disease and therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.01.012

Riluzole attenuates spinal muscular atrophy disease progression in a mouse model.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.01.012

Lentivector-mediated SMN replacement in a mouse model of spinal muscular atrophy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.01.012

Adeno-associated virus vectors can be efficiently produced without helper virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.01.012

A non-sequence-specific requirement for SMN protein activity: the role of aminoglycosides in inducing elevated SMN protein levels

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.01.012

An in vivo reporter system for measuring increased inclusion of exon 7 in SMN2 mRNA: potential therapy of SMA

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.01.012